# Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides

> **NCT07442630** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **JW Pharmaceutical** · enrollment: 88 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Pitavastatin 4mg
- **DRUG:** Ezetimibe 10 mg
- **DRUG:** Placebo (for Pitavastatin/Ezetimibe)
- **DRUG:** Placebo (for Pitavastatin)

## Key facts

- **NCT ID:** NCT07442630
- **Lead sponsor:** JW Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-21
- **Primary completion:** 2026-01-22
- **Final completion:** 2026-11-30
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2026-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07442630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07442630, "Long-term Comparison of Pitavastatin/Ezetimibe and Pitavastatin in Patients With Hypercholesterolemia and Elevated Triglycerides". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT07442630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*